###begin article-title 0
Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: TRG WLG AMK NKC. Performed the experiments: TRG AKS. Analyzed the data: TRG LXQ AMK NKC. Wrote the paper: TRG AMK NKC.
###end p 1
###begin p 2
Peripheral neuroblastic tumors (PNTs) share a common origin in the sympathetic nervous system, but manifest variable differentiation and growth potential. Malignant neuroblastoma (NB) and benign ganglioneuroma (GN) stand at opposite ends of the clinical spectrum. We hypothesize that a common PNT progenitor is driven to variable differentiation by specific developmental signaling pathways. To elucidate developmental pathways that direct PNTs along the differentiation spectrum, we compared the expression of genes related to neural crest development in GN and NB. In GNs, we found relatively low expression of sympathetic markers including adrenergic biosynthesis enzymes, indicating divergence from sympathetic fate. In contrast, GNs expressed relatively high levels of enteric neuropeptides and key constituents of the Hedgehog (HH) signaling pathway, including Dhh, Gli1 and Gli3. Predicted HH targets were also differentially expressed in GN, consistent with transcriptional response to HH signaling. These findings indicate that HH signaling is specifically active in GN. Together with the known role of HH activity in enteric neural development, these findings further suggested a role for HH activity in directing PNTs away from the sympathetic lineage toward a benign GN phenotype resembling enteric ganglia. We tested the potential for HH signaling to advance differentiation in PNTs by transducing NB cell lines with Gli1 and determining phenotypic and transcriptional response. Gli1 inhibited proliferation of NB cells, and induced a pattern of gene expression that resembled the differential pattern of gene expression of GN, compared to NB (p<0.00001). Moreover, the transcriptional response of SY5Y cells to Gli1 transduction closely resembled the transcriptional response to the differentiation agent retinoic acid (p<0.00001). Notably, Gli1 did not induce N-MYC expression in neuroblastoma cells, but strongly induced RET, a known mediator of RA effect. The decrease in NB cell proliferation induced by Gli1, and the similarity in the patterns of gene expression induced by Gli1 and by RA, corroborated by closely matched gene sets in GN tumors, all support a model in which HH signaling suppresses PNT growth by promoting differentiation along alternative neural crest pathways.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Park1">[1]</xref>
###xml 729 732 729 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Griffin1">[2]</xref>
###xml 904 907 904 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Matthay1">[3]</xref>
Peripheral neuroblastic tumors (PNTs) comprise a spectrum of neural crest (NC) derived neoplasms that occur along the sympathetic chain, ranging in state of differentiation and malignancy. Ganglioneuromas (GNs) are benign tumors at the most differentiated end of the spectrum, composed of large neuronal cells, surrounded by satellite cells resembling glia. Neuroblastomas (NBs) span the rest of the spectrum, varying in malignancy and displaying variable degrees of neural and glial differentiation [1]. Clinically, the position of a PNT along the spectrum is not invariably fixed, as metastatic, poorly differentiated tumors can undergo spontaneous regression. When these tumors regress, they may necrose or transform into GNs [2]. PNTs thus demonstrate a dynamic inverse correlation between differentiation and malignancy, suggesting that inducing differentiation may be a potent therapeutic strategy [3].
###end p 4
###begin p 5
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Gershon1">[4]</xref>
Developmental signaling pathways may regulate differentiation in PNTs. To identify candidate developmental signals, we analyzed differential expression of markers and determinants of neural crest differentiation in GN and NB. We have previously demonstrated that transcription factors advancing NC development are expressed at higher levels in GN than NB [4]. Using transcriptome-wide microarray analysis of GN and NB, we have found that GNs, characterized by their advanced glial and neuronal differentiation, diverge from the sympathetic phenotype of their sites of origin. These highly differentiated, stroma-rich tumors express genes typical of enteric neural and glial fate and function, including key elements on the Sonic Hedgehog (SHH) pathway. We propose that Hedgehog pathway activity re-directs PNTs from a sympathetic nervous system (SNS) differentiation trajectory to an alternative neural crest trajectory, that of the enteric nervous system (ENS).
###end p 5
###begin p 6
###xml 189 192 189 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Kenney1">[5]</xref>
###xml 247 250 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Palma1">[6]</xref>
###xml 399 402 399 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Raffel1">[7]</xref>
###xml 468 471 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Goodrich1">[8]</xref>
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Hallahan1">[9]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Jeong1">[10]</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Fu1">[11]</xref>
###xml 347 352 <span type="species:ncbi:9606">human</span>
###xml 408 414 <span type="species:ncbi:10090">murine</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
SHH is a potent regulator of development throughout the nervous system, and a potential oncogene. SHH is a mitogen for diverse CNS progenitors, including cerebellar granule cell precursors [5], and cells of the subventricular zone of the cerebrum [6]. In the cerebellum, mutations that enhance HH signaling are oncogenic, driving the formation of human medulloblastomas, both sporadic and syndromic [7], and murine medulloblastomas in transgenic Ptc+/- and SmoA1 mice [8], [9]. During peripheral neuro-ectodermal development, SHH is critical for specific differentiation of NC cells of the cranium and the gut [10], [11].
###end p 6
###begin p 7
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Chamberlain1">[12]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Jeong1">[10]</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Fu1">[11]</xref>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Sukegawa1">[13]</xref>
As NC cells emerge from the dorsal neural tube, they are outside the domain of SHH emanating from the ventral floor plate [12]. Cranial NC cells, however, encounter SHH as they migrate. HH signaling induces cranial NC cells to diverge from typical neuroectodermal fate, giving rise to tissues characteristically of mesodermal origin, including cranio-facial cartilage and bone, and the cardiac outflow tracts [10]. NC cells from the vagal region migrate into the embryonic gut and encounter SHH produced by endodermal cells. For cranial and enteric NC cells, SHH acts as mitogen and morphogen, regulating both proliferation and differentiation [11], [13].
###end p 7
###begin p 8
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
While HH signaling is essential for NC development, and is oncogenic in CNS progenitors, a role for HH signaling in PNTs has not previously been defined. Our finding of increased HH activity in GN suggested that the HH pathway might promote PNT differentiation. To test the potential of HH signaling to effect PNT behavior, we transduced NB cells with Gli1, a central effector of the transcriptional response to HH signaling. We then analyzed Gli1-transduced cells for effects on cell growth and gene expression and compared the set of genes induced in NB cells by Gli1 to the sets of genes induced by retinoic acid (RA) or differentially expressed in GN compared to NB. Our findings demonstrate HH signaling can re-direct developmental potential in PNTs, away from typical SNS phenotype, promoting alternative differentiation.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Differential gene expression
###end title 10
###begin p 11
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Smyth1">[14]</xref>
###xml 340 348 340 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007491.s001">Table S1</xref>
Analysis of gene expression by microarray of 79 PNTs, including 11 GNs and 68 NBs, strongly differentiated the two sets of tumors. For each gene in the array, we compared expression values for GNs and NBs by modified t-test [14]; 2500 probe sets representing 2107 genes were differentially expressed in GN and NB with a p-value of <0.0001 (Table S1). Among these differentially expressed genes, several patterns emerged, demonstrating that GNs differ from NBs not only in extent of differentiation but also in specification within the range of potential NC fates.
###end p 11
###begin title 12
Catecholamine biosynthesis enzymes and sympathetic neuropeptides are expressed more strongly by NB than GN
###end title 12
###begin p 13
###xml 197 204 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t001">Table 1</xref>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Tischler1">[15]</xref>
###xml 449 456 449 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t001">Table 1</xref>
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t001">Table 1</xref>
Consistent with SNS phenotype, NBs expressed comparatively high levels of catecholamine biosynthesis enzymes tyrosine hydroxylase (TH), dopa-decarboxylase (DDC) and dopamine beta-hydroxylase (DBH; Table 1). These proteins are strongly expressed by sympathetic neurons. Chromogranin A and B (CHGA, CHGB) and neuropeptide Y (NP-Y) are similarly expressed throughout the sympathetic chain [15] and, in our analysis, were specifically expressed in NBs (Table 1). The relatively high expression of sympathetic markers in NB was confirmed by qRT-PCR. GNs, in contrast, expressed these sympathetic markers poorly (Table 1).
###end p 13
###begin title 14
Measured abundance of mRNA for select genes identified by microarray analysis as differentially expressed in GN (italics) or NB (bold).
###end title 14
###begin p 15
###xml 237 245 237 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g001">Figure 1</xref>
We confirmed the differential expression of sympathetic markers in NB by immunocytochemistry for TH, DBH, CHGA and CHGB. All of these markers demonstrated similar expression patterns. Typical images of CHGA and DBH staining are shown in Figure 1. In NB and adrenal medulla, large clusters of cells strongly express TH and CHGA proteins in a cytoplasmic distribution. In both GN and enteric ganglia, expression was weaker and was limited to a subset of neurons, with many neurons demonstrating no expression. Immunostaining for CHGB appeared almost identical to CHGA, while TH strongly resembled DBH (data not shown).
###end p 15
###begin title 16
Adrenergic markers CHGA (A) and DBH (B) were expressed strongly in NB and weakly in GN.
###end title 16
###begin p 17
For each of these genes, immunocytochemistry produced intense labeling of NB, resembling the staining pattern of adrenal medulla (Ad). In contrast, in both GN and enteric ganglia, labeling was less intense, and was limited to a subset of neurons (red arrowheads), leaving other neurons unlabelled (blue arrowheads). Dotted white lines highlight the margins of the enteric ganglia.
###end p 17
###begin title 18
Differential expression of AP-2 transcription factors distinguish GN from the sympathetic lineage
###end title 18
###begin p 19
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-alpha</italic>
###xml 36 44 36 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-beta</italic>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-BarralloGimeno1">[16]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Hong1">[17]</xref>
###xml 450 459 450 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-alpha</italic>
###xml 511 514 511 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Gershon1">[4]</xref>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-beta</italic>
###xml 579 586 579 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t002">Table 2</xref>
###xml 612 621 612 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-alpha</italic>
###xml 657 665 657 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-beta</italic>
Transcription factors AP2-alpha and AP2-beta are homologous genes expressed in succession during SNS development and differentially expressed in GN and NB. Pre-migratory NC cells express AP2-alpha and this protein is essential for all NC development to proceed [16]. In contrast, post-migratory sympathoblasts express AP2-beta, which is required for adrenergic differentiation [17]. Microarray analysis confirmed, as we have previously demonstrated, AP2-alpha is expressed at higher levels in GN compared to NB [4]. In contrast, NBs expressed markedly higher levels of AP2-beta (Table 2). The down-regulation of AP2-alpha and complementary up-regulation of AP2-beta demonstrates SNS commitment specific to NB and not found in GN.
###end p 19
###begin title 20
Genes regulated by the HH pathway in other systems were differentially expressed in GN relative to NB, consistent with observed HH activity in GN.
###end title 20
###begin p 21
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</italic>
###xml 181 184 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</italic>
Messages listed in italics were predicted to be up-regulated by HH activity and were more abundant in GN. Messages listed in bold were predicted to be down-regulated by HH activity and were less abundant in GN.
###end p 21
###begin title 22
Proteins specific to the enteric nervous system are enriched in GN
###end title 22
###begin p 23
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CGRP</italic>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIP</italic>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Kirchgessner1">[18]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Zigmond1">[19]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Lindh1">[20]</xref>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFAP</italic>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Jessen1">[21]</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Elfvin1">[22]</xref>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EDNRB</italic>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Hosoda1">[23]</xref>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Puffenberger1">[24]</xref>
###xml 854 869 854 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CGRP, VIP, GFAP</italic>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EDNRB</italic>
###xml 947 954 947 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t001">Table 1</xref>
While GNs expressed low levels of sympathetic markers, genes abundant in the ENS were strongly expressed in GNs. To discern ENS from SNS phenotype we analyzed expression of calcitonin gene related peptide (CGRP), vasoactive intestinal peptide (VIP), glial acidic fibrillary protein (GFAP), and endothelin B receptor (EDNRB). CGRP and VIP are highly expressed in both enteric neurons and dorsal root ganglion cells [18], but only sporadically detectable in sympathetic neurons [19], [20]GFAP is widely expressed by enteric glia but uncommon in Schwann cells and limited to the non-myelinating subset [21], [22]. EDNRB is expressed during development in both sympathetic and enteric progenitors as well as melanoblasts but functionally required only for enteric and melanocytic differentiation [23], [24]. Microarray analysis and qRT-PCR demonstrated that CGRP, VIP, GFAP and EDNRB were all expressed at markedly higher levels in GN relative to NB (Table 1).
###end p 23
###begin p 24
###xml 160 166 160 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g002">Fig. 2</xref>
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g002">Fig. 2A</xref>
###xml 721 728 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g002">Fig. 2B</xref>
###xml 821 824 821 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Gershon1">[4]</xref>
To demonstrate differential expression of ENS markers at the cellular level, we used immunocytochemistry to detect GFAP and CGRP in tumors and control tissues (Fig. 2). In NB, as in adrenal medulla, rare scattered cells expressed CGRP. In contrast, in GN, strong CGRP expression was detected in cell bodies of almost all ganglion cells and in neuritic processes. A similar pattern appeared in the ENS, with frequent cytoplasmic labeling of neurons, and intense labeling of axons (Fig. 2A). GFAP immunostaining in NB was restricted to narrow chords of stroma. GFAP labeling was also seen in rare cells of the adrenal medulla. GN and ENS, however, demonstrated extensive GFAP labeling with a similar fibrillary appearance (Fig. 2B). We have previously demonstrated robust expression of myelin proteins by glial cells in GN [4]; the combination of myelin proteins and GFAP distinguishes the glia of GN from non-myelinating Schwann cells, suggesting instead an enteric glial phenotype. Taken together, the differential expression of multiple markers in GN confirms divergence from the sympathetic differentiation trajectory, toward an ENS phenotype, an alternative NC fate.
###end p 24
###begin title 25
Enteric NC markers CGRP (A), and GFAP (B) were expressed more strongly in GN than NB.
###end title 25
###begin p 26
Antibodies to CGRP labeled rare cells (blue arrowheads) in NB and adrenal medulla (Ad), while labeling neurons (blue arrowheads) and processes (blue arrows) throughout both GNs and enteric ganglia (gut). Antibodies to GFAP labeled stromal cords in NB and rare adrenal medullary cells (blue arrowheads). In contrast, labeling was intense and widespread in GN and in ganglia of the gut (outlines by dotted white lines).
###end p 26
###begin title 27
Hedgehog pathway ligand and transcription factors are expressed at high levels in GNs, with predicted effects on known hedgehog target genes
###end title 27
###begin p 28
###xml 72 91 72 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1, GLI2 and GLI3</italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Lee1">[25]</xref>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI3</italic>
###xml 264 271 264 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t001">Table 1</xref>
###xml 438 445 438 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t001">Table 1</xref>
Three homologous transcription factors are activated by the HH pathway: GLI1, GLI2 and GLI3. Transcriptional activation of GLI1 is a sensitive reporter of HH pathway activity[25]. Microarray and qRT-PCR demonstrated differential expression of GLI1 and GLI3 in GN (Table 1). Of the 3 HH ligands, SHH and IHH were not expressed at significantly different levels in GN or NB (data not shown). DHH, however, was specifically expressed in GN (Table 1).
###end p 28
###begin p 29
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP6</italic>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Lipinski1">[26]</xref>
###xml 248 257 248 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D2</italic>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Oliver1">[27]</xref>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR4a1</italic>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Ingram1">[28]</xref>
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t002">Table 2</xref>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP6</italic>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t001">Table 1</xref>
###xml 482 504 482 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">anti-mullerian hormone</italic>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMH</italic>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Ingram1">[28]</xref>
###xml 520 531 520 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plakoglobin</italic>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Yoon1">[29]</xref>
###xml 581 588 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t002">Table 2</xref>
To determine the impact of differential expression of HH pathway genes in GN we examined the expression of genes known to be regulated by HH signaling. Microarray analysis demonstrated up-regulation of established HH targets, including IGFBP6[26], cyclin D2[27] and NR4a1[28] (Table 2). To validate these observations, we used qRT-PCR to confirm up-regulation of IGFBP6 in a second independent set of GN (Table 1). Genes known to be down-regulated by HH pathway activity, including anti-mullerian hormone (AMH) [28] and plakoglobin[29] were specifically down-regulated in the GNs (Table 2). The differential expression of HH targets in GN demonstrates the active influence of the HH pathway.
###end p 29
###begin title 30
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
Gli1 alters the proliferation rate of NB cells
###end title 30
###begin p 31
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 441 450 441 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g003">Fig. 3a,b</xref>
To test whether HH pathway activity might direct PNT behavior, we transduced NB cell lines with Gli1 together with GFP or with GFP alone, and then sorted transduced cells to >95% purity by FACS and analyzed proliferation rate and gene expression. We verified Gli1 activity by transducing a GLI-activated luciferase reporter plasmid (data not shown). Transduction of Gli1 profoundly affected the proliferation of NB cells growing in culture (Fig. 3a,b).
###end p 31
###begin title 32
Gli1 slowed proliferation of NB cell lines while driving CGNPs to proliferate.
###end title 32
###begin p 33
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
A) Transduction of Gli1 decreased proliferation of NB cell lines SY5Y, BE2(N), BE2(C) and BE2(S). Proliferation in SH-EP1 was relatively unaffected (P>0.05) while proliferation of CGCPs was increased 19-fold. Error bars represent standard deviation normalized mean. B) Decreased proliferation of SY-Gli cells relative to SY-GFP was confirmed by measuring the mitotic rate of both lines, expressed as PH3+ cells per 1000. Error bars represent standard deviation. C) Western blot of two independent SY-Gli and SY-GFP cultures demonstrated the N-MYC expression was not affected by Gli1 transduction, while RET was strongly induced by Gli1.
###end p 33
###begin p 34
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 349 356 349 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g003">Fig. 3a</xref>
###xml 497 504 497 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g003">Fig. 3a</xref>
###xml 820 827 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g003">Fig. 3b</xref>
###xml 385 391 <span type="species:ncbi:10090">murine</span>
We studied effects of Gli1 over-expression on five NB cell lines with different characteristic patterns of growth: the rapidly proliferating lines SH-SY5Y, BE2(S), BE2(N), BE2(C), and slow-growing cell line SH-EP1. Gli1 reduced the proliferation rate of each of the rapidly growing lines, while minimally affecting the proliferation rate of SH-EP1 (Fig. 3a). In contrast, in explanted murine cerebellar granule cell progenitors (CGCPs) transduction with Gli1 increased proliferation rate 19-fold (Fig. 3a). To confirm that Gli1 reduced in proliferation of NB cells, we prepared and sorted to purity an independent set of SH-SY5Y cells transduced with Gli1 and GFP (SY-Gli) or with GFP only (SY-GFP) and quantified mitoses by PH3 immunostaining. SY-Gli1 cells demonstrated 50% decreased mitotic rate, compared to SY-GFP (Fig. 3b). Immunostaining for cleaved caspase-3, in contrast, demonstrated no increase in apoptosis in the two populations (data not shown).
###end p 34
###begin title 35
Gli1 induces NB cells to express genes directing NC development
###end title 35
###begin p 36
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007491.s002">Table S2</xref>
###xml 651 658 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t003">Table 3</xref>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 945 952 945 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t003">Table 3</xref>
###xml 1025 1029 1025 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
We determined the transcriptional response of NB cells to Gli1 by comparing gene expression of SY-Gli1 and SY-GFP by microarray hybridization. Diverse genes involved in NC development were differentially expressed. We found Gli1 induced differential expression of 193 out of 13,089 genes (228 out of 22,215 probe sets) on the U133 2.0 with a p-value of <0.0001 (Table S2). Of these 193 genes, we selected 12 developmentally relevant genes for confirmatory study by qRT-PCR, using independently prepared sets of transduced SY5Y cells raised in triplicate. qRT-PCR confirmed differential expression of 11 of 12 genes with a fold change of 2 or greater (Table 3). Up-regulation of only one of these 12 genes, SOX2, could not be confirmed. We also measured the expression of these 12 genes by qRT-PCR in SH-EP1 cells transduced with Gli1 or GFP. 6 of the 12 genes tested were up-regulated by Gli1 in SH-EP1 cells with a fold change of 2 or greater (Table 3), demonstrating both common elements in the transcriptional response to Gli1, and as well as elements that vary with the cellular context.
###end p 36
###begin title 37
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
Measured abundance of mRNA for select genes identified by microarray analysis as regulated by Gli1 in SY5Y cells.
###end title 37
###begin p 38
Genes up-regulated in GN are listed in bold.
###end p 38
###begin p 39
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 117 124 117 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t004">Table 4</xref>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KAL1</italic>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Cariboni1">[30]</xref>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Whitlock1">[31]</xref>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSX2</italic>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Han1">[32]</xref>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EDNRA</italic>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Abe1">[33]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Nair1">[34]</xref>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RET</italic>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Edery1">[35]</xref>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFRA2</italic>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Rossi1">[36]</xref>
###xml 396 403 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t004">Table 4</xref>
###xml 406 415 406 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KAL1, RET</italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFRA2</italic>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSX2</italic>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EDNRA</italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PMP22</italic>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VMAT2</italic>
###xml 678 685 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007491-t004">Table 4</xref>
Among the 193 genes regulated by Gli1 in SY5Y cells were crucial determinants of cranial and enteric NC development (Table 4). Cranial NC genes up-regulated by Gli1 included KAL1[30], [31], MSX2[32] and EDNRA[33], [34]. Genes critical to ENS development that were induced by Gli1 included RET[35] and GFRA2[36]. Gli1-regulated genes could also grouped by the different cell types they specified (Table 4): KAL1, RET and GFRA2 regulate neural fates, while MSX2 and EDNRA direct the development of bony NC derivatives. Gli1 induced glial differentiation marker PMP22 and neuronal marker VMAT2, demonstrating the potential of Gli1 to advance both neural and glial differentiation (Table 4). The observed changes in proliferation and gene expression induced by Gli1 demonstrate the potential for HH signaling to alter the behavior and differentiation trajectory of NB cells.
###end p 39
###begin title 40
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
Genetic determinants of diverse NC fates are induced by Gli1 in SY5Y cells.
###end title 40
###begin title 41
Gli1 advances differentiation of SY5Y cells
###end title 41
###begin p 42
To test further whether Gli1 advanced the differentiation of NB cells in culture, we compared the transcriptional responses of SH-SY5Y cells to either Gli1 transduction or treatment with the differentiation agent RA. RNA from SY-GFP cells treated for 48 hours with either 10 uM all-trans retinoic acid (ATRA) or vehicle was analyzed by microarray and the resulting datasets were compared to determine the sets of genes differentially expressed in response to RA. Comparison of three replicates of each condition, with p<0.0001 defined a set of 326 genes differentially expressed in SY-Gli compared to SY-GFP, and a set of 2123 differentially expressed in SY-GFP treated with ATRA or vehicle. The overlap of these two sets was striking: 147 genes were regulated by both ATRA and Gli1 in the same direction (p<0.00001 by hypergeometric test). The close correspondence between transcriptional response to Gli1 and RA supports the interpretation that Gli1 drives NB cells toward differentiation.
###end p 42
###begin p 43
The differential expression of HH pathway genes and targets in GN, the divergence of GN from SNS fate, and the induction of cranial and enteric NC genes in NB cells by Gli1, suggested that HH signaling might drive PNTs toward the GN phenotype. In order to test the hypothesis that HH activity could induce PNTs to become GNs, we determined whether the transcriptional response of NB cells to Gli1 resembled the specific gene expression pattern of GN. We compared the set of genes regulated by Gli1 in SY5Y cells to the set of genes differentially expressed in GN, compared to NB. We found highly significant overlap between the two sets. Of the 2108 genes found on the U95A array to be differentially expressed in GN with a p-value<0.0001, 1811 are represented on the U133 2.0 array and could be used for comparison. In our initial comparison of SY-Gli and SY-GFP, 193 of the 13,089 genes on the U133 2.0 array were differentially expressed with p<0.0001. Of these 193 genes, 57 genes were differentially expressed in GN compared to NB, a correlation very unlikely to occur by chance (p<0.00001 by hypergeometric test). Thus the effect of Gli1 transduction was to slow the proliferation of SH-SY5Y cells, and induce a transcriptional response that resembled both the response to RA and the specific gene expression pattern of GN.
###end p 43
###begin title 44
Absence of effect on N-Myc and up-regulation of RET by Gli1
###end title 44
###begin p 45
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Oliver2">[37]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Oppenheimer1">[38]</xref>
###xml 907 914 907 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007491-g003">Fig. 3c</xref>
The decreased proliferation and advanced differentiation of NB cells in response to Gli1 contrasted sharply with increased proliferation of Gli1-transduced CGCPs. These alternative responses to HH activity might be mediated by crucial, cell-specific differences in the underlying transcriptional response to Gli1. N-Myc is up-regulated by HH pathway activity in CGCPs and functions as an essential effector of Shh driven proliferation [37]. N-MYC is also an established oncogene in neuroblastoma. We have previously found that the RET proto-oncogene is up-regulated by RA in NB cell lines and plays an essential role in RA-induced differentiation [38]. We investigated the potential induction of N-MYC by Gli1 in PNTs by comparing N-MYC mRNA and protein levels in SY-Gli and SY-GFP cells. N-MYC mRNA expression measured by microarray did not correlate with Gli1 transduction (data not shown). Western blot (Fig. 3c) confirmed that N-MYC protein levels were not substantially altered by Gli1. In contrast, RET protein was strongly induced in SY-Gli cells, consistent with the promotion of differentiation.
###end p 45
###begin title 46
Discussion
###end title 46
###begin title 47
Differentiation in GN: SNS vs ENS phenotype
###end title 47
###begin p 48
Transcriptome analysis of PNTs revealed divergent differentiation trajectories of GN and NB. Among the many differentially expressed genes, we were able to discern a clear shift in markers for NC subsets: NBs expressed sympathetic markers while GNs expressed a pattern of differentiation markers most consistent with the ENS. Like developing ENS cells, GNs demonstrated activity of the HH pathway, marked by expression of both GLI1 and GLI3 and modulation of known HH target expression in predictable directions.
###end p 48
###begin p 49
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Quak1">[39]</xref>
###xml 616 624 <span type="species:ncbi:9606">children</span>
###xml 708 716 <span type="species:ncbi:9606">patients</span>
The ENS phenotype of neurons and glia in GN represents divergence from the characteristic pattern of SNS development in PNTs. GNs typically occur at sites along the sympathetic chain, and their progenitor cells have thus migrated as sympathoblasts. At some point after migration, however, under the influence of HH, these progenitors differentiate as ENS neurons and glia. The phenomenon of GNs arising from sites of metastatic NB, moreover, indicates this divergence may occur after malignant transformation has taken place. While the characterization of GNs as resembling ENS is novel, it has long been known that children with GN may present with gastrointestinal complaints. Enteric dysmotility in these patients has been attributed to secretion by the tumor of enteric neuropeptides [39]. The present findings place this enteric presentation within the context of NC development.
###end p 49
###begin title 50
HH pathway as morphogenic and tumor suppressive
###end title 50
###begin p 51
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
During development, HH is both a mitogen and a morphogen, regulating both proliferation and differentiation. The diverse potential effects of HH signaling allow for a range of plausible roles in GN pathogenesis. Although HH-mediated Gli1 activation can drive proliferation and tumorigenesis of cerebellar neural progenitors, and we found that Gli1 transduction increased the proliferation of CGCPs, in NB cells, Gli1 inhibited proliferation and induced expression of RA-responsive genes and genes up-regulated in GN. Our observation that Gli1 decreased proliferation of NB cells is not consistent with an oncogenic effect.
###end p 51
###begin p 52
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Shkumatava1">[40]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Galvin1">[41]</xref>
###xml 953 957 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 989 996 989 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1205 1209 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Mao1">[42]</xref>
###xml 1257 1261 1257 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Weiss1">[43]</xref>
###xml 167 176 <span type="species:ncbi:7955">zebrafish</span>
We suggest that HH acts in GN as a morphogen, driving not proliferation, but specific fate choice, promoting PNT differentiation rather than growth. In the developing zebrafish retina, SHH signaling promotes the differentiation of neuroblasts, and inhibition of SHH supports progenitor proliferation [40]. In hippocampal neural stem cells, moreover, GLI1 can limit proliferation by inducing apoptosis [41]. Accordingly, GNs may demonstrate the highest differentiation specifically because they have achieved the highest levels of HH activity, depleting tumor stem cells through apoptosis or differentiation. While we did not observe prominent induction of apoptosis by SY-Gli cells, we cannot rule out an apoptotic effect on a sub-population of cells with stem-like properties. A tumor suppressive role for HH signaling would account for the benign, differentiated phenotype of GNs and for the decrease in proliferation of NB cells on transduction with Gli1. This hypothesis may be tested in vivo, and the role of HH signaling in NC development and PNT pathogenesis may be further elucidated, through xenograft studies and animal primary PNTs models, using targeted activation of Smo to drive HH activity [42] and targeted activation of MYCN to induce PNTs [43].
###end p 52
###begin title 53
DHH and Schwann cell mediated differentiation in GN
###end title 53
###begin p 54
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Hallahan1">[9]</xref>
The mechanism of HH pathway activation in GN is not clear. The HH pathway may be activated through a cell autonomous mechanism, as seen in medulloblastomas in which mutant SMO is constitutively active [9]. We did not detect differential expression of SMO in GN, but the possibility of activating mutations in GN remains to be evaluated. Alternatively, the HH signaling may be activated by ligand binding.
###end p 54
###begin p 55
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-SharghiNamini1">[44]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Kwiatkowski1">[45]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Liu1">[46]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Parmantier1">[47]</xref>
HH signaling in GN could be mediated by DHH, which, like GLI1 and GLI3 is differentially expressed in these benign tumors. Schwann cells in peripheral nerves secrete DHH [44], and GNs are largely composed of cells that resemble Schwann cells. Several lines of evidence have demonstrated that Schwann cells secrete factors that promote differentiation of NB cells [45], [46]. DHH may contribute to this inductive interaction, and glial cells within GN may, unlike typical Scwhann cells [47], respond to DHH in an autocrine manner, to enforce and advance differentiation.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Tissue Samples
###end title 57
###begin p 58
###xml 201 206 <span type="species:ncbi:9606">Human</span>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
This study was conducted according to the principles expressed in the Declaration of Helsinki. The study was approved by the Memorial Sloan-Kettering Cancer Center Institutional Review Board (IRB) and Human Tumor Utilization Committee (HTUC). All patients provided written informed consent for the collection of samples and subsequent analysis.
###end p 58
###begin title 59
Cell culture techniques
###end title 59
###begin p 60
###xml 358 359 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 493 495 487 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 229 232 <span type="species:ncbi:9685">cat</span>
Neuroblastoma cell lines were kindly provided by R. Ross and B. Spengler (Fordham University, Fordham, NY). HEK293E cells (Invitrogen) were used for retroviral packaging. All cell lines were maintained in Opti-MEM with Glutamax (cat#51985; Invitrogen) supplemented with 10% FCS and penicillin/streptomycin at 37degreesC in a humidified environment with 5% CO2. For RA treatment, SY-GFP cells were plated in triplicate sets in 10 cm plates and allowed to adhere for 24 hours, after which 1/1000th volume of 10 mM retinoic acid dissolved in 100% EtOH, or vehicle alone was added to the medium. After 48 hours in ATRA, cells were processed for microarray.
###end p 60
###begin p 61
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 370 373 <span type="species:ncbi:9685">cat</span>
Murine Gli1 and GFP were transduced into NB cells using a bi-cistronic retroviral plasmid, pLZIR-GLI (gift of Robert Wechsler-Reya, PhD, Duke University). Control cells were transduced with GFP, using pWZL-GFP. Retroviral stocks were prepared by co-transfecting HEK293E cells with Gag-Pol and VSVG plasmids along with the either pLZIR-GLI or pWZL-GFP, using Fugene 6.0 (cat#11814443001; Roche). Packaging cells were transferred to 32 C 24 hours after transfection, and viral stocks were harvested at 48 and 36 hours. For transduction, NB cells were exposed to retroviral stock at 32 C for 4-6 hours, recovered for 3-4 days at 37 C and sorted for GFP expression by FACS. GFP+ populations were then recovered and expanded through 2-3 passages before use in experiments.
###end p 61
###begin p 62
###xml 129 132 <span type="species:ncbi:9685">cat</span>
Proliferating cells were labeled by EdU and Alexa647 using the Invitrogen Click-iT EdU Alexa Fluor 647 Flow Cytometry Assay kit (cat# A10202), then analyzed by FACS. For PH3 and caspase staining, 50,000 cells per well were plated in 96 well plates and maintained in culture for 2 days, then fixed in 4% formaldehyde, immunostained for PH3 and counterstained with DAPI. We performed automated quantification of PH3+ and DAPI+ cells with 8-fold replicates using an INCell 1000 automated microscope (GE/Amersham Biosciences).
###end p 62
###begin title 63
Microarray analysis
###end title 63
###begin p 64
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Alaminos1">[48]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Irizarry1">[49]</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Smyth1">[14]</xref>
###xml 206 209 <span type="species:ncbi:9685">cat</span>
Microarray hybridization of tumor derived samples was carried out on Affymetrix U95A chips, as previously described [48]. RNA was prepared from SY-Gli and SY-GFP cell lines using Trizol Reagent (Invitrogen cat# 15596026), processed and analyzed on Affymetrix U133 2.0 chips, according to manufacturer's protocol. All microarray expression data were processed with Robust Multichip Analysis (RMA; R software; the R Foundation for Statistical Computing) [49]. Differential expression analysis was performed to identify genes between sample groups applying an Empirical Bayes t test to each gene [14]. All microarray data are described in accordance with MIAME guidelines. Microarray data are deposited in the caArray Array Data Management System, Experiment Identifier gersh-00292.
###end p 64
###begin p 65
To derive gene lists for comparison, a p-value cutoff of 0.0001 was used to select differentially expressed genes. The number of tests (i.e. probesets) with p<0.0001 expected by chance equals 0.0001x total number of probesets. For the U95 platform, which is used for the tumor sample study, the total of number of probesets is 12,533 and hence 1 probeset is expected to have a p-value<0.0001 just by chance. For the U133A platform, which is used for the cell line study, the total of number of probesets is 22,215 and hence 2 probesets are expected to have a p-value<0.0001 just by chance. The actual sets of genes demonstrating differential expression with p<0.0001 were compiled, and a hypergeometric test was then used to calculate the probability of overlapping sets.
###end p 65
###begin title 66
Quantitative real-time reverse transcriptase PCR (qRT-PCR)
###end title 66
###begin p 67
###xml 618 626 618 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007491.s003">Table S3</xref>
We confirmed gene expression patterns noted by microarray by qRT-PCR using a 2-step method. Total RNA for template was purified from tumor and cell line samples independent from those used for microarray; 12-18 tumor samples and 12 cell line samples were used in each qRT-PCR assay. First strand cDNA was synthesized using the Superscript III kit (Invitrogen). We performed qRT-PCR reactions on the BioRad iCycler and IQ SYBR Green Master Mix (170-8882; BioRad). All reactions were performed in duplicate. All primer pairs were designed to span at least 1 intron-exon boundaries, except for VIP, which has no introns (Table S3). Each primer pair was validated by RT-PCR and the products were cloned and sequenced to confirm specificity. Cloned PCR products were then used as copy number standards for qRT-PCR. Each primer pair yielded measured Ct values in control reactions that varied linearly with the log of copy number over at least 6 orders of magnitude. We normalized all values to the measured expression of beta actin (BA). Fold change was computed by comparing the median copy number for each group.
###end p 67
###begin title 68
Immunocytochemistry and Western blots
###end title 68
###begin p 69
###xml 218 221 218 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007491-Gershon1">[4]</xref>
###xml 513 521 513 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007491.s003">Table S3</xref>
All immunocytochemistry was performed on paraffin embedded material from pathology archives of The Memorial Sloan-Kettering Cancer Center (MSKCC). Antigen retrieval and staining techniques were as previously described [4]. Cultured cells were not subjected to antigen retrieval. For Western blots, SY-Gli and SY-GFP cells were prepared in triplicate wells, and lysed in situ, then subjected to SDS-PAGE, and developed using chemiluminescence. Sources of primary antibodies and concentrations used are as listed ( Table S3).
###end p 69
###begin title 70
Supporting Information
###end title 70
###begin p 71
Genes differentially expressed in GN compared to NB. Mean values are computed from log2 transformed expression values. The difference in log2 transformed means is therefore equal to log2 (fold change).
###end p 71
###begin p 72
(4.10 MB DOC)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
Genes differentially expressed in SY5Y cells tranduced with Gli1 and GFP or GFP only. Mean values are computed from log2 transformed expression values. The difference in log2 transformed means is therefore equal to log2 (fold change).
###end p 74
###begin p 75
(0.33 MB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
Primers and antibodies used
###end p 77
###begin p 78
(0.03 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Tumor extraction and annotation was performed by Yi Feng in the Cheung Lab and Yonghong Zhao in the Gerald lab, both at MSKCC. Expert advice in the interpretation of neuroblastoma cell morphology was provided by Dr. Robert Ross (Fordham University, Fordham, NY). Expert editing was performed by Joseph Olechnowicz, MSKCC.
###end p 80
###begin title 81
References
###end title 81
###begin article-title 82
Neuroblastoma: biology, prognosis, and treatment.
###end article-title 82
###begin article-title 83
Familial neuroblastoma with regression and maturation to ganglioneurofibroma.
###end article-title 83
###begin article-title 84
###xml 146 154 <span type="species:ncbi:9606">Children</span>
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
###end article-title 84
###begin article-title 85
Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
###end article-title 85
###begin article-title 86
Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors.
###end article-title 86
###begin article-title 87
Sonic hedgehog controls stem cell behavior in the postnatal and adult brain.
###end article-title 87
###begin article-title 88
Sporadic medulloblastomas contain PTCH mutations.
###end article-title 88
###begin article-title 89
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Altered neural cell fates and medulloblastoma in mouse patched mutants.
###end article-title 89
###begin article-title 90
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.
###end article-title 90
###begin article-title 91
Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia.
###end article-title 91
###begin article-title 92
Sonic hedgehog regulates the proliferation, differentiation, and migration of enteric neural crest cells in gut.
###end article-title 92
###begin article-title 93
Notochord-derived Shh concentrates in close association with the apically positioned basal body in neural target cells and forms a dynamic gradient during neural patterning.
###end article-title 93
###begin article-title 94
The concentric structure of the developing gut is regulated by Sonic hedgehog derived from endodermal epithelium.
###end article-title 94
###begin article-title 95
Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
###end article-title 95
###begin article-title 96
Divergent differentiation in neuroendocrine tumors of the adrenal gland.
###end article-title 96
###begin article-title 97
###xml 45 54 <span type="species:ncbi:7955">zebrafish</span>
Neural crest survival and differentiation in zebrafish depends on mont blanc/tfap2a gene function.
###end article-title 97
###begin article-title 98
Regulation of the noradrenaline neurotransmitter phenotype by the transcription factor AP-2beta.
###end article-title 98
###begin article-title 99
Markers shared between dorsal root and enteric ganglia.
###end article-title 99
###begin article-title 100
Regulation of neuropeptide expression in sympathetic neurons. Paracrine and retrograde influences.
###end article-title 100
###begin article-title 101
###xml 90 93 <span type="species:ncbi:9685">cat</span>
NPY-, galanin-, VIP/PHI-, CGRP- and substance P-immunoreactive neuronal subpopulations in cat autonomic and sensory ganglia and their projections.
###end article-title 101
###begin article-title 102
Molecular identity, distribution and heterogeneity of glial fibrillary acidic protein: an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytes.
###end article-title 102
###begin article-title 103
###xml 82 85 <span type="species:ncbi:10116">rat</span>
###xml 90 100 <span type="species:ncbi:10141">guinea-pig</span>
Neurofilament-like and glial fibrillary acidic protein-like immunoreactivities in rat and guinea-pig sympathetic ganglia in situ and after perturbation.
###end article-title 103
###begin article-title 104
###xml 134 138 <span type="species:ncbi:10090">mice</span>
Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice.
###end article-title 104
###begin article-title 105
A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease.
###end article-title 105
###begin article-title 106
Gli1 is a target of Sonic hedgehog that induces ventral neural tube development.
###end article-title 106
###begin article-title 107
Sonic hedgehog signaling regulates the expression of insulin-like growth factor binding protein-6 during fetal prostate development.
###end article-title 107
###begin article-title 108
Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors.
###end article-title 108
###begin article-title 109
Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells.
###end article-title 109
###begin article-title 110
Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation.
###end article-title 110
###begin article-title 111
The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons.
###end article-title 111
###begin article-title 112
###xml 132 141 <span type="species:ncbi:7955">zebrafish</span>
###xml 143 154 <span type="species:ncbi:7955">Danio rerio</span>
Gonadotropin-releasing hormone (GnRH) cells arise from cranial neural crest and adenohypophyseal regions of the neural plate in the zebrafish, Danio rerio.
###end article-title 112
###begin article-title 113
Concerted action of Msx1 and Msx2 in regulating cranial neural crest cell differentiation during frontal bone development.
###end article-title 113
###begin article-title 114
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Fate of cranial neural crest cells during craniofacial development in endothelin-A receptor-deficient mice.
###end article-title 114
###begin article-title 115
###xml 152 161 <span type="species:ncbi:7955">zebrafish</span>
Requirements for Endothelin type-A receptors and Endothelin-1 signaling in the facial ectoderm for the patterning of skeletogenic neural crest cells in zebrafish.
###end article-title 115
###begin article-title 116
Mutations of the RET proto-oncogene in Hirschsprung's disease.
###end article-title 116
###begin article-title 117
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Alimentary tract innervation deficits and dysfunction in mice lacking GDNF family receptor alpha2.
###end article-title 117
###begin article-title 118
Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors.
###end article-title 118
###begin article-title 119
The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma.
###end article-title 119
###begin article-title 120
###xml 51 59 <span type="species:ncbi:9606">children</span>
Vasoactive intestinal peptide secreting tumours in children: a case report with literature review.
###end article-title 120
###begin article-title 121
###xml 57 66 <span type="species:ncbi:7955">zebrafish</span>
Shh directs cell-cycle exit by activating p57Kip2 in the zebrafish retina.
###end article-title 121
###begin article-title 122
Gli1 induces G2/M arrest and apoptosis in hippocampal but not tumor-derived neural stem cells.
###end article-title 122
###begin article-title 123
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.
###end article-title 123
###begin article-title 124
###xml 52 67 <span type="species:ncbi:10090">transgenic mice</span>
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
###end article-title 124
###begin article-title 125
###xml 97 112 <span type="species:ncbi:262775">desert hedgehog</span>
The structural and functional integrity of peripheral nerves depends on the glial-derived signal desert hedgehog.
###end article-title 125
###begin article-title 126
Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation.
###end article-title 126
###begin article-title 127
'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
###end article-title 127
###begin article-title 128
###xml 21 36 <span type="species:ncbi:262775">Desert hedgehog</span>
Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths.
###end article-title 128
###begin article-title 129
###xml 64 69 <span type="species:ncbi:9606">human</span>
Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.
###end article-title 129
###begin article-title 130
Exploration, normalization, and summaries of high density oligonucleotide array probe level data.
###end article-title 130
###begin p 131
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 131
###begin p 132
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 13 18 <span type="species:ncbi:9606">Child</span>
Funding: The Child Neurology Foundation,  The Morgan Adams Foundation,  The Robert Steel Foundation. The Andrew Witmer Fund. National Institutes of Health CA106450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 132

